Narendra Singh Selected Research

Narendra Singh Research Topics

Disease

6	Neoplasms (Cancer) 12/2021 - 11/2012
6	Inflammation (Inflammations) 11/2021 - 01/2019
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2021 - 01/2021
3	Neuroinflammatory Diseases 01/2021 - 03/2016
3	Multiple Sclerosis 01/2018 - 01/2014
2	Dysbiosis 11/2021 - 01/2021
2	Hypersensitivity (Allergy) 01/2021 - 01/2021
2	Critical Illness (Critically Ill) 01/2020 - 09/2014
2	Myocardial Infarction 01/2019 - 01/2016
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 03/2016
2	Acute Coronary Syndrome 01/2016 - 06/2013
2	Hyperlipidemias (Hyperlipidemia) 01/2012 - 03/2002
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Hypoxia (Hypoxemia) 11/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021
1	Sepsis (Septicemia) 01/2020
1	Death (Near-Death Experience) 11/2019
1	Prediabetic State (Prediabetes) 09/2019
1	Obesity 09/2019
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Atherosclerosis 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Whooping Cough (Pertussis) 01/2019
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Hypercalcemia (Milk Alkali Syndrome) 12/2018
1	Hyperparathyroidism 12/2018
1	Spontaneous Fractures (Pathological Fracture) 12/2018
1	Paralysis (Palsy) 01/2018
1	Communicable Diseases (Infectious Diseases) 04/2016
1	Asthma (Bronchial Asthma) 03/2016
1	Neuralgia (Stump Neuralgia) 03/2016
1	Herpes Zoster 03/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2016
1	Parkinson Disease (Parkinson's Disease) 03/2016
1	Atrial Fibrillation 01/2016
1	Heart Failure 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2015

Drug/Important Bio-Agent (IBA)

4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2014
3	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2021 - 07/2005
3	LigandsIBA 01/2021 - 01/2019
2	EndocannabinoidsIBA 11/2021 - 01/2021
2	anandamide (arachidonylethanolamide)IBA 11/2021 - 01/2021
2	FlavonoidsIBA 01/2021 - 03/2016
2	methylated bovine serum albumin (MBSA)IBA 01/2021 - 01/2021
2	ApigeninIBA 01/2021 - 03/2016
2	CopperIBA 12/2019 - 11/2019
2	Monoclonal AntibodiesIBA 01/2019 - 11/2012
2	C-Reactive ProteinIBA 01/2019 - 01/2012
2	AntioxidantsIBA 03/2016 - 04/2015
2	LipidsIBA 01/2016 - 07/2015
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 12/2021
1	Peptides (Polypeptides)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	NaphthalimidesIBA 12/2021
1	Tight Junction ProteinsIBA 11/2021
1	Oxygen (Dioxygen)IBA 11/2021
1	Butyrates (Butyrate)IBA 01/2021
1	carbazoleIBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	SuperantigensIBA 01/2021
1	ResveratrolIBA 01/2021
1	staphylococcal enterotoxin BIBA 01/2021
1	6-formylindolo(3,2-b)carbazoleIBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	ProcalcitoninIBA 01/2020
1	BromineIBA 01/2020
1	CarcinogensIBA 01/2020
1	tetrabromobisphenol AIBA 01/2020
1	ZincIBA 12/2019
1	SilverIBA 12/2019
1	IronIBA 11/2019
1	AluminumIBA 11/2019
1	AntimonyIBA 11/2019
1	PlasticsIBA 11/2019
1	Blood Glucose (Blood Sugar)IBA 09/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Virulence Factors (Pathogenicity Factors)IBA 01/2019
1	Pertussis ToxinIBA 01/2019
1	EnzymesIBA 01/2019
1	CytokinesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	canakinumab FDA Link 01/2019
1	Parathyroid Hormone (Parathormone)IBA 12/2018
1	CannabinoidsIBA 01/2018
1	CannabidiolIBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2016
1	empagliflozinIBA 01/2016
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2016
1	AnticoagulantsIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2015

Therapy/Procedure

5	Therapeutics 01/2021 - 11/2012
1	Precision Medicine 12/2021
1	Cathode Ray Tube 11/2019
1	Percutaneous Coronary Intervention 01/2016